Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 163
Filter
1.
Acta Paediatr ; 104(11): 1169-73, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26081020

ABSTRACT

AIM: Sclerotherapy is the primary treatment for lymphatic malformations. The aim of this study was to evaluate the long-term outcome in patients with lymphatic malformations treated with the immunostimulant OK-432 as a sclerosant. METHODS: Between 1998 and 2013, we enrolled 131 of 138 eligible patients treated with OK-432 for lymphatic malformations in a retrospective study. The malformations were categorised according to the International Society for the Study of Vascular Anomalies. The outcome was assessed with a clinical examination and a questionnaire. RESULTS: The lymphatic malformations were localised to the head/neck (60%), the trunk (20%) and the extremities (6%) or involved with more than one region (14%). Patients with microcystic (10%), macrocystic (21%) and mixed lymphatic malformations (69%) underwent a median number of three, two and two injection treatments, respectively. The median age at the first injection was 3.4 years. Good or excellent clinical outcomes were seen in 70% of the patients. The number of injections, previous treatment and lesion localisation, but not time to follow-up and cyst size, predicted the clinical outcome. CONCLUSION: OK-432 treatment resulted in a successful outcome in 70% of patients with lymphatic malformations. The long-term outcome was comparable to the short-term outcome.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Lymphatic Abnormalities/therapy , Picibanil/therapeutic use , Sclerotherapy , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Remission Induction , Retrospective Studies , Time Factors , Treatment Outcome , Young Adult
2.
Int J Tuberc Lung Dis ; 12(2): 199-204, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18230254

ABSTRACT

SETTING: City of Stockholm, Sweden. BACKGROUND: The incidence of tuberculosis (TB) in Sweden increased by 40% between 2003 and 2005. The spread of a unique TB strain resistant to isoniazid (INH) contributed to this increase. OBJECTIVE: To describe outbreaks of TB caused by this single strain, elucidate possible causes for its extensive spread and identify shortcomings of the TB control programme in Sweden. RESULTS: We identified a cluster consisting of 102 culture-confirmed TB cases with identical DNA fingerprints and 26 epidemiologically related cases, not confirmed by culture, all diagnosed between 1996 and 2005. Five partly separate outbreaks of this strain were discovered. Epidemiological links were established for 56% of the culture-confirmed cases and for all cases not confirmed by culture. Three patients died while receiving treatment, four became failures and eight defaulted or were lost to follow-up. Only eight patients received directly observed treatment (DOT) up to a period of 3 months, although 40% had poor adherence. CONCLUSIONS: Shortcomings of the national TB programme were revealed. Improved contact tracing and case holding, including DOT, is crucial to reduce TB transmission in Sweden.


Subject(s)
Antitubercular Agents/pharmacology , Disease Outbreaks , Isoniazid/pharmacology , Mycobacterium tuberculosis/drug effects , Tuberculosis, Pulmonary/epidemiology , Adolescent , Adult , Antitubercular Agents/therapeutic use , Child , Child, Preschool , Cluster Analysis , Contact Tracing , DNA Fingerprinting , Directly Observed Therapy , Disease Outbreaks/prevention & control , Female , Humans , Infant , Isoniazid/therapeutic use , Male , Middle Aged , Mycobacterium tuberculosis/genetics , Sweden/epidemiology , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/prevention & control , Tuberculosis, Pulmonary/transmission
3.
APMIS ; 115(11): 1281-4, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18092961

ABSTRACT

Candida dubliniensis is phenotypically similar to Candida albicans and may therefore be underdiagnosed in the clinical microbiology laboratory. The performance of Bichro-Dubli latex agglutination test for rapid species identification of C. dubliniensis was prospectively evaluated on 111 vaginal and 118 respiratory isolates. These had presumptively been identified as C. albicans/C. dubliniensis by their green colonies on CHROMagar Candida plates. Bichro-Dubli test identifed 2 (1.8%) vaginal and 6 (5.1%) respiratory isolates as C. dubliniensis. The test was also positive for 37 C. dubliniensis control strains characterised by 18S-28S DNA-sequencing. Bichro-Dubli test is thus a sensitive and accurate tool for rapid diagnostics in routine laboratories.


Subject(s)
Candida albicans/classification , Candida/classification , Latex Fixation Tests/methods , Bronchoalveolar Lavage Fluid/microbiology , Candida/growth & development , Candida/isolation & purification , Candida albicans/growth & development , Candida albicans/isolation & purification , Diagnostic Tests, Routine , Female , Humans , Sputum/microbiology , Vagina/microbiology
4.
Eur J Clin Microbiol Infect Dis ; 25(10): 609-13, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17047903

ABSTRACT

Mycobacterium marinum is a waterborne mycobacterium that commonly infects fish and amphibians worldwide. Infection in humans occurs occasionally, in most cases as a granulomatous infection localized in the skin, typically following minor trauma on the hands. For this reason, infection is especially common among aquarium keepers. Such local infection may-though infrequently-spread to tendon sheaths or joints. Disseminated disease, which is rare, can occur in immunosuppressed patients. In order to obtain a definitive diagnosis, culture and histopathological examination of biopsies from skin or other tissues are recommended. Infections sometimes heal spontaneously, but drug treatment is usually necessary for several months in order to cure the infection. Doxycycline or clarithromycin is used most commonly, although in severe cases, a combination of rifampicin and ethambutol is recommended.


Subject(s)
Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium marinum/isolation & purification , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/metabolism , Animals , Fish Diseases/microbiology , Humans , Mycobacterium Infections, Nontuberculous/diagnosis , Skin Diseases, Bacterial/diagnosis , Water Microbiology
5.
Mycopathologia ; 161(3): 167-72, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16482389

ABSTRACT

To assess the clinical and fungal species spectrum of dermatophyte infection in a reference centre in Addis Ababa, 539 dermatological patients with signs of dermatophytosis were investigated. Seventy-one percent were female and 29% male, aged 2-66 years (median 9). Four hundred-fifteen (77%) had at least one skin lesion. Tinea capitis was diagnosed in 138/155 males (89%) as compared to 214/384 females (40%) (p < 0.05). T. capitis was diagnosed in 69% of the 374 children. Fingernails were affected in 132/145 (91%) of onychomycosis, 118 (90%) of these patients were females and 14 males (p < 0.05). Tinea corporis was observed in 45, and other types of tinea in 12 patients. Thirty-six percent of all patients had also other skin lesions, mostly impetigo. Of 490 cultured samples 364 (74%) grew dermatophytes: Trichophyton violaceum in 84%, Trichophyton verrucosum in 9.6%, Trichophyton tonsurans in 1.4% and T. rubrum in 0.5%. Additionally, 15 isolates were identified as white variants of T. violaceum, in 3 cases confirmed by sequencing of the rDNA ITS 2 region. T. capitis in young males and T. unguium of fingernails in females were the most common manifestations of dermatophytosis in Addis Ababa, usually caused by T.violaceum.


Subject(s)
Nails/microbiology , Tinea/epidemiology , Trichophyton/growth & development , Adolescent , Adult , Age Factors , Aged , Child , Child, Preschool , DNA, Fungal/chemistry , DNA, Fungal/genetics , DNA, Ribosomal Spacer/chemistry , DNA, Ribosomal Spacer/genetics , Ethiopia/epidemiology , Female , Humans , Male , Middle Aged , Polymerase Chain Reaction , Prevalence , Tinea/microbiology , Trichophyton/genetics
6.
APMIS ; 113(10): 708-12, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16309431

ABSTRACT

Certain dermatophytes are geographically restricted and endemic in particular parts of the world, while other species may have a sporadic but worldwide distribution. Trichophyton violaceum is one of the most common dermatophytes causing tinea capitis, and is the predominant cause of tinea in Africa, South America and the Indian subcontinent. Among 1187 dermatophyte isolates collected from Ethiopian patients with various types of tinea, 32 isolates had uncharacteristic phenotypic features. Based on conventional methods complemented by sequence analysis of the rDNA ITS2 region, these isolates were identified as white variants of T. violaceum. This is the first time that white isolates of T. violaceum have been identified in Ethiopia.


Subject(s)
Tinea/microbiology , Trichophyton/isolation & purification , Adolescent , Adult , Base Sequence , Child , Child, Preschool , DNA, Fungal/genetics , DNA, Ribosomal/genetics , DNA, Ribosomal Spacer/genetics , Ethiopia , Humans , Male , Molecular Sequence Data , Pigments, Biological , Sequence Alignment , Sequence Analysis, DNA , Species Specificity , Trichophyton/chemistry , Trichophyton/classification , Trichophyton/genetics
7.
Mycoses ; 48(2): 137-41, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15743433

ABSTRACT

The prevalence of dermatophytosis and the spectrum of dermatophyte species were determined in children attending two schools in Addis Ababa, Ethiopia. Demographic and clinico-dermatological data were collected. Specimens were taken for microscopy and culture from all suspected lesions. Dermatophyte species were identified by morphology and biochemical tests, supplemented by sequencing of the rDNA ITS 2 region in selected isolates. From the Biruh Tesfa Elementary School (BTES) 824 students, and from Mount Olive Academy (MOA) all 124 students, were included. In BTES 513 (62.3%) students were clinically diagnosed with dermatophytosis, 463 (90.3 %) of them with tinea capitis. In 200 consecutive samples from BTES, and in 66 from MOA, 75 and 62%, respectively, contained fungal elements at microscopy. From BTES, 163/496 (33%) samples were culture-positive, of which 149 (91.4%) grew with dark purple colonies identified as Trichophyton violaceum, while 244 (49.4%) samples were contaminated. A few strains grew slowly developing white to cream colonies, two were identified as T. verrucosum, and 12 as white T. violaceum. From MOA 44 (66.7%) of samples were culture-positive, 38 (87%) were identified as T. violaceum, and one (2.3%) as T. verrucosum, while 33% showed no growth. Four white isolates of T.violaceum were confirmed by DNA-sequencing. Dermatophytosis was thus diagnosed in 55-62% of children screened at two schools of different socioeconomic standards in the Ethiopian capital. Trichophyton violaceum constituted 87-90% of all isolates. White variants of T. violaceum were diagnosed in 16 cases.


Subject(s)
Tinea Capitis/epidemiology , Trichophyton/classification , Trichophyton/isolation & purification , Adolescent , Child , Child, Preschool , DNA, Fungal/chemistry , DNA, Fungal/isolation & purification , DNA, Intergenic/chemistry , DNA, Intergenic/isolation & purification , DNA, Ribosomal/chemistry , DNA, Ribosomal/isolation & purification , Ethiopia/epidemiology , Female , Humans , Male , Mycological Typing Techniques , Prevalence , Sequence Analysis, DNA , Tinea Capitis/microbiology , Trichophyton/cytology , Trichophyton/physiology
8.
Sex Transm Infect ; 80(1): 54-7, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14755037

ABSTRACT

OBJECTIVE: To study the prevalence of vulvovaginal candida among sexually active adolescents. To determine past and present symptoms, including pain at intercourse and potential behavioural risk factors associated with vulvovaginal candidiasis. METHODS: At an adolescent centre, 219 sexually active women who underwent genital examination, also completed a questionnaire on a history of genital symptoms and infections, sexual and hygiene habits, and the use of contraceptives. Symptoms and clinical signs were registered. Vaginal samples were analysed for candida species and urine for Chlamydia trachomatis. RESULTS: Candida culture was positive in 42% of the women and only 15% were asymptomatic. A history of recurrent candidiasis was given by 22%. Frequent pain at intercourse was reported by 24% and frequent oro-genital sex by 42% of the women. Frequent pain at intercourse was significantly associated with both the growth of candida and a history of recurrent candidiasis. Oro-genital sex was an independent risk factor for the growth of candida. CONCLUSION: In sexually active adolescents, who underwent genital examination, candida cultures were positive in 42%. The habit of frequent oro-genital sex was associated with the growth of candida. Pain at intercourse was associated with the growth of candida and recurrent candidiasis.


Subject(s)
Candidiasis, Vulvovaginal/epidemiology , Dyspareunia/epidemiology , Sexual Behavior , Adolescent , Adult , Child , Female , Humans , Prevalence , Recurrence , Regression Analysis , Sweden/epidemiology
9.
Clin Microbiol Infect ; 9(11): 1148-52, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14616736

ABSTRACT

We evaluated the BacT/ALERT 3D system for recovery and drug susceptibility testing (DST) of Mycobacterium tuberculosis (MTB). Of 2659 clinical specimens, MTB was detected in 92 using BacT/ALERT, compared to 94 using Löwenstein-Jensen culture. Detection time was 25% shorter with BacT/ALERT. Sensitivities were 92%, 96%, 78% and 100% for resistance to rifampicin, isoniazid, streptomycin and ethambutol, respectively, while specificity was 100% for all antibiotics, when BacT/ALERT was compared with the BACTEC 460 method on 50 MTB isolates. The BacT/ALERT system is fully automated and creates no radioactive waste. It seems to be a valid alternative for primary isolation, but further evaluation is needed regarding DST.


Subject(s)
Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/isolation & purification , Reagent Kits, Diagnostic/standards , Tuberculosis/microbiology , Humans , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/standards , Sensitivity and Specificity , Specimen Handling/methods
10.
Int J Tuberc Lung Dis ; 7(9): 899-902, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12971676

ABSTRACT

In the first attempt to establish a quality assurance programme for susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones, 20 strains with different fluoroquinolone susceptibility patterns were distributed by the Supranational Reference Laboratory in Stockholm to the other mycobacterial reference laboratories of the Nordic and Baltic countries. Susceptibility testing to fluoroquinolones was performed according to routine procedures in each laboratory. Results were compared to sequence analysis of the gyrA gene and minimal inhibitory concentration determination. Most laboratories found identical susceptibility patterns. The two resistant strains were correctly identified by all laboratories, but three laboratories each falsely reported one susceptible strain as resistant. These results indicate that the participating laboratories yield reliable results in detection of fluoroquinolone-resistant strains, although the need for a standardised quality assurance programme for drug susceptibility testing for fluoroquinolones is stressed by the strains falsely reported as resistant.


Subject(s)
Antitubercular Agents/pharmacology , Drug Resistance, Multiple , Fluoroquinolones/pharmacology , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/pathogenicity , Tuberculosis, Pulmonary/drug therapy , Baltic States , Drug Resistance, Bacterial , False Positive Reactions , Humans , International Cooperation , Laboratories , Microbial Sensitivity Tests , Norway , Reference Values , Reproducibility of Results , Sweden
11.
Acta Paediatr ; 92(8): 910-5, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12948065

ABSTRACT

AIM: To evaluate the response rate to antimycobacterial drug therapy in patients with cystic fibrosis (CF) suffering from infection by non-tuberculous mycobacteria (NTM). METHODS: Ten patients, aged 10-34 y, out of 180 CF patients, were diagnosed with NTM disease. They had been regularly checked and examined for pulmonary symptoms, and had had chest X-rays and sputum cultures (including for mycobacteria) performed. One additional 36-y-old female received her CF diagnosis soon after the NTM diagnosis. RESULTS: Mycobacterium avium-intracellulare complex (MAC) was found in 10 out of 11 patients and M. kansasii in 1 patient. Treatment with antimycobacterial drugs resulted in clinical improvement (weight gain or stabilization of weight and/or improved or stabilized lung function in 8 out of 11 patients) and mycobacterial culture turned negative in 10 out of 1. CONCLUSION: Promising results may be associated with early intervention with antimycobacterial therapy in CF patients.


Subject(s)
Antitubercular Agents/therapeutic use , Cystic Fibrosis/complications , Ethambutol/therapeutic use , Mycobacterium Infections, Nontuberculous/complications , Mycobacterium Infections, Nontuberculous/drug therapy , Adolescent , Adult , Amikacin/therapeutic use , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Antitubercular Agents/adverse effects , Child , Clarithromycin/therapeutic use , Cohort Studies , Cystic Fibrosis/drug therapy , Ethambutol/adverse effects , Female , Humans , Male , Mycobacterium avium Complex/isolation & purification , Mycobacterium avium-intracellulare Infection/complications , Mycobacterium avium-intracellulare Infection/drug therapy , Mycobacterium kansasii/isolation & purification , Retrospective Studies , Rifampin/adverse effects , Rifampin/therapeutic use , Streptomycin/therapeutic use
12.
Acta Paediatr ; 92(8): 980-2, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12948078

ABSTRACT

UNLABELLED: Scedosporium prolificans is an environmental mould that may cause local infection in bone and joints after traumatic implantation, or generalized infection in immunocompromised patients. The fungus is highly drug resistant, both in vitro and in vivo. We present a case of osteomyelitis and arthritis caused by S. prolificans in a 9-y-old boy whose knee had been punctured by a hawthorn spike. Treatment with different drugs was difficult and arthrodesis was necessary. Concomitantly, voriconazole was given, and after three months bone biopsies were sterile despite a high in vitro MIC-value of the fungus against voriconazole. Reversible skin depigmentation and fingernail oncholysis appeared toward the end of 17 months of voriconazole treatment. Twelve months after discontinuation of treatment, no signs of relapse were detected. CONCLUSION: Voriconazole may be a valuable adjunct to surgical treatment of bone and joint infection by Scedosporium prolificans.


Subject(s)
Arthritis, Infectious/etiology , Bone Diseases, Infectious/etiology , Knee Injuries/complications , Mycetoma/etiology , Scedosporium , Wounds, Penetrating/complications , Arthritis, Infectious/diagnosis , Arthritis, Infectious/drug therapy , Arthritis, Infectious/surgery , Bone Diseases, Infectious/diagnosis , Bone Diseases, Infectious/drug therapy , Bone Diseases, Infectious/surgery , Child , Crataegus , Humans , Knee Injuries/diagnostic imaging , Knee Injuries/microbiology , Knee Injuries/surgery , Male , Radiography , Wounds, Penetrating/microbiology
13.
Bone Marrow Transplant ; 31(6): 511-3, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12665849

ABSTRACT

Infections are responsible for a large part of the morbidity and mortality after BMT because of the sustained impairment of host defenses. We report a case of cutaneous infection caused by Mycobacterium szulgai in a boy who underwent BMT with marrow from a matched unrelated donor.


Subject(s)
Bone Marrow Transplantation/adverse effects , Mycobacterium Infections, Nontuberculous/diagnosis , Nontuberculous Mycobacteria , Opportunistic Infections/diagnosis , Skin Diseases, Bacterial/diagnosis , Child, Preschool , Humans , Male , Opportunistic Infections/microbiology , Transplantation, Homologous
16.
Lakartidningen ; 98(30-31): 3330-2, 2001 Jul 25.
Article in Swedish | MEDLINE | ID: mdl-11521336

ABSTRACT

Botryomycosis is a chronic granulomatous infection, usually of skin or mucous membranes in predisposed individuals. Infection in internal organs may occur in immunosuppressed persons and is serious but uncommon. Trauma or foreign bodies and defective immune defense mechanisms predispose for the disease, which is mainly caused by Staphylococcus aureus, but also by other bacteria. The histopathological picture is diagnostic and biopsy is encouraged in granulomatous infections. Differential diagnoses may be mycobacteriosis, mycosis and parasitosis. If excision, the preferred treatment, is not radical, prolonged antibiotic treatment is required. The disease may become more widespread in connection with the common use of piercing in young immunocompetent persons.


Subject(s)
Gram-Positive Bacterial Infections/microbiology , Granuloma/microbiology , Mouth Mucosa/pathology , Skin Diseases, Infectious/microbiology , Aged , Biopsy , Cheek/pathology , Diagnosis, Differential , Female , Gram-Positive Bacterial Infections/pathology , Gram-Positive Bacterial Infections/therapy , Granuloma/pathology , Granuloma/therapy , Humans , Mouth Mucosa/microbiology , Skin Diseases, Infectious/pathology , Skin Diseases, Infectious/therapy
17.
Am J Physiol Endocrinol Metab ; 281(2): E197-206, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11440894

ABSTRACT

The present study was designed to determine whether consumption of an oral essential amino acid-carbohydrate supplement (EAC) before exercise results in a greater anabolic response than supplementation after resistance exercise. Six healthy human subjects participated in two trials in random order, PRE (EAC consumed immediately before exercise), and POST (EAC consumed immediately after exercise). A primed, continuous infusion of L-[ring-(2)H(5)]phenylalanine, femoral arteriovenous catheterization, and muscle biopsies from the vastus lateralis were used to determine phenylalanine concentrations, enrichments, and net uptake across the leg. Blood and muscle phenylalanine concentrations were increased by approximately 130% after drink consumption in both trials. Amino acid delivery to the leg was increased during exercise and remained elevated for the 2 h after exercise in both trials. Delivery of amino acids (amino acid concentration times blood flow) was significantly greater in PRE than in POST during the exercise bout and in the 1st h after exercise (P < 0.05). Total net phenylalanine uptake across the leg was greater (P = 0.0002) during PRE (209 +/- 42 mg) than during POST (81 +/- 19). Phenylalanine disappearance rate, an indicator of muscle protein synthesis from blood amino acids, increased after EAC consumption in both trials. These results indicate that the response of net muscle protein synthesis to consumption of an EAC solution immediately before resistance exercise is greater than that when the solution is consumed after exercise, primarily because of an increase in muscle protein synthesis as a result of increased delivery of amino acids to the leg.


Subject(s)
Amino Acids, Essential/administration & dosage , Carbohydrates/administration & dosage , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Physical Exertion/physiology , Administration, Oral , Adult , Biopsy , Blood Flow Velocity/drug effects , Deuterium , Dietary Supplements , Female , Humans , Infusions, Intravenous , Insulin/blood , Leg , Male , Phenylalanine/administration & dosage , Phenylalanine/blood , Phenylalanine/pharmacokinetics , Protein Biosynthesis , Regional Blood Flow/drug effects , Time Factors
18.
Scand J Infect Dis ; 33(4): 316-9, 2001.
Article in English | MEDLINE | ID: mdl-11345227

ABSTRACT

Pulmonary mucormycosis is a usually fatal opportunistic infection in immunocompromised patients. We describe the first case of an adult patient with hematological malignancy and profound neutropenia to survive a disseminated pulmonary Rhizomucor pusillus infection. Early diagnostic procedures combined with high doses of liposomal amphotericin B and surgical resection may have contributed to the successful outcome.


Subject(s)
Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Leukemia-Lymphoma, Adult T-Cell/complications , Lung Diseases, Fungal/therapy , Mucormycosis/therapy , Rhizomucor , Amphotericin B/administration & dosage , Antifungal Agents/administration & dosage , Combined Modality Therapy , Humans , Leukemia-Lymphoma, Adult T-Cell/diagnostic imaging , Liposomes , Lung Diseases, Fungal/complications , Lung Diseases, Fungal/diagnostic imaging , Male , Middle Aged , Mucormycosis/complications , Mucormycosis/diagnostic imaging , Neutropenia/etiology , Pneumonectomy , Radiography , Treatment Outcome
19.
Acta Paediatr ; 90(3): 323-7, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11332175

ABSTRACT

UNLABELLED: Malassezia pachydermatis, a non-obligatory lipophilic yeast, has occasionally been implicated in nosocomial fungaemias. This study investigated a cluster of eight cases of M. pachydermatis infection and colonization in a neonatal intensive care unit over a 6 mo period. All patients were preterm with very low birthweight and suffered from various underlying diseases. Prolonged use of indwelling catheters and parenteral lipid formulations were important predisposing factors for their infection. All M. pachydermatis strains were susceptible to amphotericin B, fluconazole and itraconazole but resistant against flucytosine. CONCLUSION: Molecular typing by random amplification of polymorphic DNA showed distinct banding profiles for each blood isolate. Since no epidemiological association among the strains could be shown, the reason for this cluster of nosocomial fungaemias remains unclear.


Subject(s)
Cross Infection/diagnosis , Fungemia/diagnosis , Infant, Premature, Diseases/diagnosis , Malassezia , Antifungal Agents/pharmacology , Cross Infection/epidemiology , Fungemia/epidemiology , Humans , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/epidemiology , Infant, Very Low Birth Weight , Intensive Care Units, Neonatal , Malassezia/drug effects , Malassezia/genetics , Malassezia/isolation & purification , Microbial Sensitivity Tests , Random Amplified Polymorphic DNA Technique , Retrospective Studies
20.
Scand J Infect Dis ; 32(4): 440-1, 2000.
Article in English | MEDLINE | ID: mdl-10959663

ABSTRACT

Coccidioidomycosis, an endemic fungal infection of the western hemisphere causes serious disease in immunocompromised individuals. In immunocompetent patients, a moderate flu-like disease may develop. We report here an imported Scandinavian case of a culture-proven coccidioidomycosis, initially presenting as an atypical pneumonia. Pleuritic symptoms, positive epidemiology and eosinophilia led to suspicion of the diagnosis, which was further supported by serology.


Subject(s)
Coccidioidomycosis/complications , Pneumonia/etiology , Aged , Coccidioidomycosis/drug therapy , Humans , Male , Pneumonia/drug therapy , Sweden
SELECTION OF CITATIONS
SEARCH DETAIL
...